1-3 of 3
Gretchen Henstorf
Close
Sort by
Journal Articles

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford, Muneer Abidi, Chien-Shing Chen, J. David Godwin, Theodore A. Gooley, Leona Holmberg, Gretchen Henstorf, C. Fred LeMaistre, Maureen D. Mayes, Kevin T. McDonagh, Bernadette McLaughlin, Jerry A. Molitor, J. Lee Nelson, Howard Shulman, Rainer Storb, Federico Viganego, Mark H. Wener, James R. Seibold, Keith M. Sullivan, Daniel E. Furst
Journal: Blood
Blood (2007) 110 (4): 1388–1396.
https://doi.org/10.1182/blood-2007-02-072389
Published: 2007
Journal Articles

Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc).

Richard A. Nash, Peter McSweeney, Leslie Crofford, Kevin T. McDonagh, Maureen Mayes, J. Lee Nelson, Ted Gooley, Leona Holmberg, Howard Shulman, Mark Wener, Bernadette McLaughlin, Gretchen Henstorf, Jerry Molitor, James Seibold, Keith Sullivan, Daniel Furst
Journal: Blood
Blood (2006) 108 (11): 3071.
https://doi.org/10.1182/blood.V108.11.3071.3071
Published: 2006
Journal Articles

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Peter McSweeney, MD, Daniel Furst, MD, Leslie Crofford, MD, Kevin McDonagh, MD, Keith Sullivan, MD, Mayes Maureen, MD, Nelson Lee, MD, Theodore Gooley, Ph.D., Jan Storek, MD, PhD, Leona Holmberg, MD, PhD, C.S. Chen, MD, PhD, Mark Wener, MD, Julie Lee, RN, Gretchen Henstorf, CCRC, Muneer Abidi, MD, Philip Mease, MD, Richard Nash, MD
Journal: Blood
Blood (2004) 104 (11): 149.
https://doi.org/10.1182/blood.V104.11.149.149
Published: 2004